Working paper Open Access

Vitamin D for Covid-19?

Sparavigna, Amelia Carolina

A small survey of literature about Vitamin D  and inhibition and expression of interleukins and tumor necrosis factors. Could Vitamin D have a possible role in Covid-19 Cytokine Release Syndrome?  A study of its role when tocilizumab is used exists, and therefore Vitamin D could be considered when tocilizumab is involved in the mitigation of the cytokine storm. However, another question also exists and it is the following. Might Vitamin D induce antimicrobial peptides to reduce SARS-CoV-2 replication?

Files (129.6 kB)
Name Size
vitamin-D.pdf
md5:84eff5dd1e7a04490c9924def7c6a23c 		129.6 kB Download
414
87
views
downloads
All versions This version
Views 414414
Downloads 8787
Data volume 11.3 MB11.3 MB
Unique views 389389
Unique downloads 7676
More info on how stats are collected.
Indexed in
Publication date:
May 12, 2020
DOI:
10.5281/zenodo.3822187

Zenodo DOI Badge

DOI 

10.5281/zenodo.3822187

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.3822187.svg)](https://doi.org/10.5281/zenodo.3822187)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.3822187.svg
   :target: https://doi.org/10.5281/zenodo.3822187

HTML 

<a href="https://doi.org/10.5281/zenodo.3822187"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.3822187.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.3822187.svg

Target URL 

https://doi.org/10.5281/zenodo.3822187

Keyword(s):
Cytokines Interleukins TNF Vitamin D Tocilizumab
Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.3822187 May 12, 2020
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.3822186. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export